Cardlytics (NASDAQ:CDLX) released its quarterly earnings data on Tuesday. The company reported ($0.15) earnings per share for the quarter, topping the Zacks’ consensus estimate of ($0.63) by $0.48, Bloomberg Earnings reports. The company had revenue of $34.58 million for the quarter, compared to analyst estimates of $37.62 million. Cardlytics’s quarterly revenue was up 10.1% compared to the same quarter last year. Cardlytics updated its Q4 2018 guidance to EPS and its FY 2018 guidance to EPS.
NASDAQ:CDLX traded down $0.53 on Tuesday, reaching $17.75. The company’s stock had a trading volume of 140,548 shares, compared to its average volume of 168,480. Cardlytics has a 12-month low of $11.10 and a 12-month high of $28.29. The company has a quick ratio of 2.24, a current ratio of 2.24 and a debt-to-equity ratio of 1.29. The company has a market capitalization of $389.88 million and a P/E ratio of -2.21.
A number of research firms have weighed in on CDLX. Zacks Investment Research raised Cardlytics from a “sell” rating to a “hold” rating in a research note on Wednesday, September 19th. SunTrust Banks reissued a “buy” rating and set a $27.00 price objective on shares of Cardlytics in a research note on Tuesday, September 11th. KeyCorp lowered their price objective on Cardlytics from $30.00 to $28.00 and set an “overweight” rating on the stock in a research note on Wednesday, August 15th. Finally, Bank of America reissued a “hold” rating and set a $22.00 price objective on shares of Cardlytics in a research note on Friday, August 17th. Two investment analysts have rated the stock with a hold rating and five have issued a buy rating to the company’s stock. The stock has an average rating of “Buy” and a consensus price target of $24.40.
A hedge fund recently raised its stake in Cardlytics stock. Bank of New York Mellon Corp raised its holdings in Cardlytics Inc (NASDAQ:CDLX) by 32.9% during the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 15,553 shares of the company’s stock after purchasing an additional 3,846 shares during the quarter. Bank of New York Mellon Corp owned 0.08% of Cardlytics worth $338,000 as of its most recent SEC filing. 53.48% of the stock is owned by institutional investors.
Cardlytics, Inc operates a purchase intelligence platform in the United States and the United Kingdom. It operates in two segments, Cardlytics Direct and Other Platform Solutions. The company's platform is the Cardlytics Direct solution, a proprietary native bank advertising channel that enables marketers to reach consumers through their trusted and frequently visited online and mobile banking channels.
See Also: Tariff
Receive News & Ratings for Cardlytics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardlytics and related companies with MarketBeat.com's FREE daily email newsletter.